GEN Homepage

Translational Medicine

BIO 2026: CEO Calls for U.S. Biotech Urgency and International Competitiveness

John Crowley emphasized industry modernization and solving “man-made problems” to outcompete rivals like China through improved U.S. innovation ecosystems.

California Still Golden Despite Job Losses: Industry Group

First-in-Human Stem Cell Therapy Trial for Huntington’s Disease Begins at UCI Health

Medra Launches Reasoning Layer for Drug Discovery Robotics

InduPro Licenses Lonza’s Linker Payload Technologies and Bioconjugation Platforms

Translational Medicine

A Method for Assessing Lab-Grown Stem Cell-Derived Embryo Models

Researchers developed a method for testing how closely lab-grown blastoid models resemble real human embryos, finding that while some models perform well, none fully captures the complexity of early human development.

Infectious Diseases

Phage Proteases Trigger a Conserved Bacterial Antiviral Defense Pathway

Drug Discovery

Anti-Inflammatory Drug Target for Alzheimer’s, TBI, and Neurodegenerative Disease Identified

Translational Medicine

Flicking the Switch: Five Scientists Honored at 2026 Warren Alpert Foundation Symposium for Hemoglobinopathy Research

Videos

From organoid models to pathology, AI is increasingly embedded across cancer research areas. Fay Lin, PhD, and Jonathan D. Grinstein, PhD, discuss how challenges, such as adoption and trust continue to hinder AI’s impact on patient outcomes.

From the AACR Annual Meeting in San Diego, Julianna LeMieux and Damian Doherty report on early highlights, including key insights and takeaways from the first few days of the meeting.

A Lists

Top 10 Contract Development and Manufacturing Organizations 2026

A majority of biopharmas are expected to increase their reliance on CDMOs in coming years despite rising costs for their services.

10 CDMO Up & Comers 2026

As one notable company exits the field, growing CDMOs open facilities and secure major contracts.

Next 10 U.S. Biopharma Clusters

For the first time, GEN examines the top regions and top states just below the 10 largest regions for life sciences activity, as the field looks beyond the East and West Coasts for growth.

Resources

Magazine

Issue No. 6, June 2026

GEN Magazine

Drug Discovery

Next Generation Biopharma Innovation

In a quest to provide more relevant translational data, traditional in vivo models join forces with new approach methodologies.

Translational Medicine

Organ Chips Move Towards Mainstream Drug Development, with Hurdles Ahead

Drug Discovery

Targeted Protein Degradation Broadens Its Scope

Drug Discovery

Top 10 U.S. Biopharma Clusters 2026

GEN Digital Edition

Access the latest issue of GEN and browse the archive of back issues when you subscribe to our digital edition.

Latest Resources

featured|

AAVs in Focus: Practical Approaches to Capsid Analytics and Plasmid DNA Control

In this special three part series, experts from USP and industry will share first-hand experiences, case studies, and practical insights on how AAV analytics and material controls are evolving. This series will identify common AAV challenges and explore effective solutions across different stages of development.

Webinars|

Oct 8, 2026 11:00 AM

Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies

Webinars|

Oct 9, 2026 11:00 AM

The Next Wave of ADC Innovation: The Science Behind Dual-Payload Bioconjugates

Webinars|

Oct 15, 2026 11:00 AM

Advancing Cell Therapy for Cardiovascular Disease

Webinars|

Oct 20, 2026 11:00 AM

Translational Medicine

BIO 2026: CEO Calls for U.S. Biotech Urgency and International Competitiveness

Translational Medicine

California Still Golden Despite Job Losses: Industry Group

Translational Medicine

First-in-Human Stem Cell Therapy Trial for Huntington’s Disease Begins at UCI Health

Artificial Intelligence

Medra Launches Reasoning Layer for Drug Discovery Robotics

Cancer

InduPro Licenses Lonza’s Linker Payload Technologies and Bioconjugation Platforms

Translational Medicine

A Method for Assessing Lab-Grown Stem Cell-Derived Embryo Models

Infectious Diseases

Phage Proteases Trigger a Conserved Bacterial Antiviral Defense Pathway

Drug Discovery

Anti-Inflammatory Drug Target for Alzheimer’s, TBI, and Neurodegenerative Disease Identified

Translational Medicine

Flicking the Switch: Five Scientists Honored at 2026 Warren Alpert Foundation Symposium for Hemoglobinopathy Research

Videos

Top 10 Contract Development and Manufacturing Organizations 2026

10 CDMO Up & Comers 2026

Next 10 U.S. Biopharma Clusters

Issue No. 6, June 2026

GEN Magazine

Drug Discovery

Next Generation Biopharma Innovation

Translational Medicine

Organ Chips Move Towards Mainstream Drug Development, with Hurdles Ahead

Drug Discovery

Targeted Protein Degradation Broadens Its Scope

Drug Discovery

Top 10 U.S. Biopharma Clusters 2026

GEN Digital Edition

featured|

AAVs in Focus: Practical Approaches to Capsid Analytics and Plasmid DNA Control

Webinars|

Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies

Webinars|

The Next Wave of ADC Innovation: The Science Behind Dual-Payload Bioconjugates

Webinars|

Advancing Cell Therapy for Cardiovascular Disease

Webinars|

Emerging Trends in Fluid Transfers and Freeze-Thaw Workflows

Artificial Intelligence

Basecamp Research Raise $140M Series C Financing Toward Advancing AI-Designed Drugs

Translational Medicine

StockWatch: Novo’s 2030 Strategy Underwhelms Investors at Capital Markets Day

Translational Medicine

Lilly’s GIP/GLP-1 Candidate Brenipatide Shows Early Clinical Promise in Substance, Psych Disorders